骨质疏松症中的罗莫苏祖马布:昨天,今天和明天
1Department of Orthopeadics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China.
Journal of translational medicine
|September 27, 2023
概括
一种新的骨质疏松症药物罗莫苏祖马布 (Romosozumab) 通过促进骨生长显示出有前途,但它具有诸如心血管事件等风险. 本审查审查了其发展,临床使用和安全性.
科学领域:
- 骨生物学和药理学 骨生物学和药理学
- 内分泌学和新陈代谢
- 药物开发和临床试验 药物开发和临床试验
背景情况:
- 骨质疏松症是全球主要的健康问题,特别是在老龄化人口和绝经后妇女中.
- 目前的骨质疏松症治疗有局限性和不良影响,缺乏对骨的双重作用.
- 罗莫索祖马布是一种向硬质素的单克隆抗体,代表了一种新的治疗方法.
研究的目的:
- 为提供罗莫苏祖马布用于骨质疏松症治疗的综合性审查.
- 根据临床前和临床数据分析罗莫苏祖马布的疗效,安全性和临床应用.
- 为了解决争议,并提供一个平衡的理解药物的潜力.
主要方法:
- 对罗莫苏祖马布 (romosozumab) 的动物和人类研究进行系统审查.
- 分析有关骨形成和再吸收效应的数据.
- 评估报告的不良事件,包括心血管风险.
- 评估成本效益和临床指导方针.
主要成果:
- 罗莫苏祖马布显示骨迅速形成,骨矿物质密度显著改善.
- 临床研究表明,在降低骨折风险方面具有有效性.
- 报告了包括心血管风险在内的潜在严重不良事件,导致了持续的辩论.
结论:
- 罗莫索祖马布为骨质疏松症提供了一种新型的合成代谢机制,显示出有前途的疗效.
- 由于潜在的心血管风险,仔细选择和监测患者至关重要.
- 需要进一步的研究和长期数据来充分确定其在骨质疏松症管理中的作用.
相关概念视频
01:31Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
01:40Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
01:17Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
01:29Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:30Hormonal Control of the Ovarian Cycle
555
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
555